/
•
•
Detailed stories on technology startups, business and economic current affairs.
The market has shown a surge in demand for primary offerings, which means the interest in Medi Assist could be for potential listing gains. But could there be more at play here?

Despite a diversification push, over half its revenue continues to come from the volatile and highly regulated equity derivatives segment.
The Saudi-backed EV maker says claims of a possible collapse are untrue, but investors remain worried about the company’s future.
The newly listed insurer commands a premium valuation, but its latest ambition, if not done right, may prove to be a drag.